Patent Box claims reach £942.5 million

No items found.
October 1, 2018
No items found.

New preliminary data published by the UK Government for the tax year ending 2017 shows companies have saved a total of £942.5 million in tax relief by using Patent Box. When full results are published in 2019 this figure could even exceed £1 billion.

Patent Box is a UK Government scheme which allows companies to apply a lower rate of Corporation Tax on profits gained from patented inventions, from 19% to 10%. The Patent Box was introduced in 2013 to increase the level of patenting and development of IP created in the UK. The scheme also encourages companies to locate high-value jobs associated with the development of patents in the UK.

James Seymour, Partner at EIP, said: “Patent Box provides an incentive for UK companies to innovate in the UK, and to develop and commercialise their intellectual property globally. Data from the most recent complete financial year, 2015-16, shows that the benefits can be significant, with 1,160 companies using the Patent Box to claim an average of more than £650,000 relief. However, the Patent Box is not only for large companies, as those classed as small or medium accounted for almost half the total claimants, claiming on average more than £55,000 of tax relief each.”

Any UK company that owns and profits from a patented invention may be eligible to benefit from Patent Box, potentially saving them thousands of pounds in Corporation Tax. The savings achieved in tax relief may also offset the costs of the patenting process, making it potentially a sound investment for those considering filing for patent protection.

James added: “While it is clear that UK companies are taking notice of the Patent Box, with the total relief increasing significantly year-on-year, there are thousands more who are potentially missing out on the substantial savings available.”

If you would like to learn more about Patent Box and how it can help your business, visit our dedicated Patent Box website, Patentise, or contact James Seymour.

Recent Case Reports

Scripps mRNA reengineering patent found invalid and not infringed by Comirnaty
08 September 2026
The Local Division Munich invalidated Promosome's licensed mRNA patent over Scripps' codon-optimisation method, then found BioNTech's Comirnaty vaccine would not have infringed the claims even had they been valid.
Fujifilm v Kodak: clarifying the defence of dependent claims and inventive-step combinations at the UPC
27 August 2026
The Court of Appeal gave guidance on defending dependent claims, relying on EPO central limitation during UPC proceedings, and pleading revocation attacks. It also emphasised that inventive-step combinations require a proper pointer to the secondary reference.
Can Reference Numerals Influence Claim Interpretation?
21 August 2026
In T 0903/24, the EPO Board of Appeal relied on reference numerals to interpret disputed claim language, rejecting the patentee's narrower reading and revoking novelty over prior art D2 for the main request.